-
341
Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19
Published 2022-01-01“…In conclusion, further studies are required to investigate the role and function of immunosuppressive cells and their potentials as prognostic biomarkers and therapeutic targets in COVID-19 patients.…”
Get full text
Article -
342
Xylohypha bantiana Multiple Brain Abscesses in a Patient with Systemic Lupus Erythematosus
Published 2003-01-01“…We report on a 72-year-old man who, while taking several immunosuppressive medications for systemic lupus erythematosus, presented with multiple bilateral cerebral abscesses caused by X bantiana. …”
Get full text
Article -
343
Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma
Published 2025-01-01“…This group of Treg cells has stronger immunosuppressive function and was associated with a worse prognosis in ccRCC cohorts. …”
Get full text
Article -
344
A Case of Oral Histoplasmosis Concomitant with Pulmonary Tuberculosis
Published 2019-01-01“…The human immunodeficiency virus (HIV) infection test was negative. The immunosuppression caused by tuberculosis in our patient probably had an important role in the development of intraoral lesions of histoplasmosis. …”
Get full text
Article -
345
Wernicke’s Encephalopathy: An Unusual Consequence of the Acquired Immune Deficiency Syndrome—Case Report and Literature Review
Published 2013-01-01“…Wernicke’s has been described in patients with acquired immune deficiency syndrome (AIDS); however, given these patients’ immunosuppressed state, the diagnosis of Wernicke’s encephalopathy is not apparent. …”
Get full text
Article -
346
PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis
Published 2012-01-01“…With careful reduction of the immunosuppression after the first manifestation and with the use of chemotherapy combined with radiotherapy after the second manifestation, our patient showed complete disappearance of neurologic symptoms and she is clinically well with good kidney function. …”
Get full text
Article -
347
A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy
Published 2014-01-01“…Moreover, enhanced biologic functions of T cells generated by genetic engineering and modified immunosuppressive microenvironment of host by homeostatic T cell expansion and/or elimination of immunosuppressive cells and molecules can induce more potent antitumor T cell responses and make this strategy hold promise in promoting a patient response for malignant glioma treatment. …”
Get full text
Article -
348
Acute fibrinous and organizing pneumonia after lung transplantation: A case report of treatment with infliximab and tocilizumab and literature review
Published 2025-01-01“…Treatment is empiric, based on immunosuppressive regimens and the mortality rate is very high. …”
Get full text
Article -
349
It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
Published 2025-01-01“…Gal-9 significantly contributes to the immunosuppressive milieu of PDAC by interacting with various immune cells, such as T cells, macrophages, and myeloid-derived suppressor cells (MDSCs). …”
Get full text
Article -
350
Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor
Published 2020-01-01“…She achieved sustained complete remission with transplant nephroureterectomy, retroperitoneal lymphadenectomy, immunosuppression withdrawal, and immunotherapy with pembrolizumab. …”
Get full text
Article -
351
Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma
Published 2013-01-01“…An imbalance of immunosuppressive cells and cytotoxic cells plays an important role in inhibiting the antitumor immune response of the tumor-bearing host. …”
Get full text
Article -
352
Leiomyoma in a Renal Allograft
Published 2016-01-01“…The patient was converted to everolimus for posttransplant immunosuppression management and there was no sign of progression over a year.…”
Get full text
Article -
353
Leclercia adecarboxylata Musculoskeletal Infection in an Immune Competent Pediatric Patient: An Emerging Pathogen?
Published 2015-01-01“…Leclercia adecarboxylata has increasing reports in immunosuppressed and adult patients with musculoskeletal infection. …”
Get full text
Article -
354
Tuberculosis-Associated Immune Reconstruction Inflammatory Syndrome (TB-IRIS) in HIV-Infected Patients: Report of Two Cases and the Literature Overview
Published 2013-01-01“…TB-IRIS in HIV-infected subjects is an exacerbation of the symptoms, signs, or radiological manifestations of a pathogenic antigen, related to recovery of the immune system after immunosuppression. We focused on the radiological characteristics of TB-IRIS and the briefly literature review on this syndrome.…”
Get full text
Article -
355
Invasive Group B Streptococcal Disease in Two Pediatric Patients with Systemic Lupus Erythematosus
Published 2013-01-01“…We report two patients with SLE who were treated with steroids and immunosuppressive medication and then developed invasive Group B Streptococcus (GBS) infections. …”
Get full text
Article -
356
Anti-Factor H Antibodies in Egyptian Children with Hemolytic Uremic Syndrome
Published 2021-01-01“…All patients who started immunosuppressives early together with plasmapheresis upon detection of their anti-FH had complete renal function recovery. …”
Get full text
Article -
357
Infections in systemic lupus erythematosus: A study of incidence and risk factors in 100 patients from western India
Published 2022-01-01“…Management of SLE needs vigilance for infection and judicious use of immunosuppressive drugs.…”
Get full text
Article -
358
Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort...
Published 2025-01-01“…Disease activity (SLE Disease Activity Index 2000 (SLEDAI-2K)), average oral glucocorticoid dose and use of other treatments—specifically antimalarials, biologics and immunosuppressants—were measured over time. Subgroup analyses were stratified by baseline interferon gene signature (IFNGS) status and disease activity (SLEDAI-2K) status.Results Patient demographics and baseline characteristics were similar among subgroups; the majority of patients were on antimalarials (n=670; 81.1%), followed by glucocorticoids (n=537; 65.0%), immunosuppressants (n=453; 54.8%) and biologics (n=175; 21.2%). …”
Get full text
Article -
359
Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients
Published 2000-01-01“…OKT3, a murine monoclonal antibody specific to the human CD3 complex, induces immunosuppression by depletion of T cells. Administration of OKT3 results in significant release of proinflammatory cytokines, such as TNFα and IL1β. …”
Get full text
Article -
360
Vascular Endograft Infection with Listeria monocytogenes reated with Surgical Debridement but without Graft Removal
Published 2011-01-01“…The awareness of Listeria monocytogenes as a pathogen in meningitis and bacteremia in immunosuppressed patients is high. We report a case of vascular graft infection due to Listeria monocytogenes as an example of a less well-known manifestation of listeriosis and focus on the possible treatment procedures emphasizing a management with surgical debridement but preservation of the endograft, in contrast to the gold standard treatment of vascular graft infections which consists of a removal of the graft.…”
Get full text
Article